NL
DFTX

NVWM LLC’s Definium Therapeutics DFTX Stock Holding History

NVWM LLC’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.86K Hold
416
– – ﹤0.01% 319
2025
Q4 		$5.57K Hold
416
– – ﹤0.01% 349
2025
Q3 		$4.91K Hold
416
– – ﹤0.01% 349
2025
Q2 		$2.7K Hold
416
– – ﹤0.01% 384
2025
Q1 		$2.43K Hold
416
– – ﹤0.01% 369
2024
Q4 		$2.9K Hold
416
– – ﹤0.01% 347
2024
Q3 		$2.37K Hold
416
– – ﹤0.01% 361
2024
Q2 		$3K Hold
416
– – ﹤0.01% 341
2024
Q1 		$3.91K Hold
416
– – ﹤0.01% 325
2023
Q4 		$1.52K Buy
+416
New +$1.25K ﹤0.01% 369

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NVWM LLC's DFTX Position: Q1 2026 in Review

NVWM LLC held its Definium Therapeutics (DFTX) position steady in Q1 2026 at 416 shares worth $7.86K. The position accounts for ﹤0.01% of the portfolio, ranked #319.

NVWM LLC first reported a position in DFTX in Q4 2023 and has held it in 10 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • NVWM LLC held 416 shares of Definium Therapeutics worth $7.86K as of Q1 2026.
  • NVWM LLC left its Definium Therapeutics share count unchanged in Q1 2026.
  • Definium Therapeutics made up ﹤0.01% of NVWM LLC's portfolio in Q1 2026, its #319 holding.
  • NVWM LLC first reported a position in Definium Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on NVWM LLC's 13F filing for Q1 2026, filed 27 Apr 2026.